Log In
BCIQ
Print this Print this
 

AR01

  Manage Alerts
Collapse Summary General Information
Company Arbor Pharmaceuticals Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat pain associated with acute otitis media
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today